17 | fludarabineIBA
12/2021
-
01/2002 |
16 | Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018
-
10/2002 |
15 | Clofarabine (Clolar)FDA Link
01/2018
-
03/2003 |
14 | NucleosidesIBA
01/2019
-
09/2002 |
13 | DNA (Deoxyribonucleic Acid)IBA
12/2019
-
01/2002 |
9 | 2'- cyano- 2'- deoxyarabinofuranosylcytosineIBA
12/2019
-
08/2005 |
8 | GemcitabineFDA Link
11/2014
-
02/2002 |
7 | Proteins (Proteins, Gene)FDA Link
01/2019
-
10/2005 |
6 | Rituximab (Mabthera)FDA Link
12/2021
-
06/2005 |
6 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2021
-
02/2002 |
6 | sapacitabineIBA
01/2018
-
01/2010 |
6 | ProdrugsIBA
01/2018
-
02/2002 |
6 | triphosphoric acid (triphosphate)IBA
03/2008
-
10/2002 |
5 | Antineoplastic Agents (Antineoplastics)IBA
02/2010
-
05/2003 |
4 | MicroRNAs (MicroRNA)IBA
12/2016
-
10/2007 |
4 | Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2013
-
12/2006 |
4 | 7-hydroxystaurosporine (UCN 01)IBA
05/2007
-
02/2002 |
3 | Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022
-
05/2009 |
3 | venetoclaxIBA
01/2022
-
01/2019 |
3 | ibrutinibIBA
12/2021
-
01/2019 |
3 | Arabinofuranosylcytosine TriphosphateIBA
01/2018
-
10/2002 |
3 | Messenger RNA (mRNA)IBA
09/2013
-
10/2005 |
3 | DNA-Activated Protein KinaseIBA
08/2011
-
01/2008 |
3 | N- (5- (((5- (1,1- dimethylethyl)- 2- oxazolyl)methyl)thio)- 2- thiazolyl)- 4- piperidinecarboxamideIBA
08/2010
-
05/2009 |
3 | CladribineFDA LinkGeneric
07/2006
-
10/2002 |
2 | Apoptosis Regulatory ProteinsIBA
01/2022
-
01/2021 |
2 | Phosphotransferases (Kinase)IBA
01/2021
-
01/2008 |
2 | Agammaglobulinaemia Tyrosine KinaseIBA
01/2019
-
12/2016 |
2 | Purine NucleosidesIBA
01/2018
-
11/2017 |
2 | Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2018
-
11/2017 |
2 | Transaminases (Aminotransferases)IBA
11/2017
-
06/2014 |
2 | Ligases (Synthetase)IBA
01/2016
-
04/2009 |
2 | alvocidib (flavopiridol)IBA
02/2015
-
10/2005 |
2 | HomoharringtonineIBA
04/2014
-
01/2011 |
2 | bcr-abl Fusion ProteinsIBA
04/2014
-
11/2006 |
2 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
09/2013
-
12/2003 |
2 | DeoxycytidineIBA
08/2012
-
01/2010 |
2 | NK314IBA
08/2011
-
05/2007 |
2 | ChromatinIBA
12/2010
-
01/2008 |
2 | rabacfosadineIBA
06/2009
-
05/2008 |
2 | NucleotidesIBA
06/2009
-
05/2008 |
2 | nelarabine (506U78)FDA Link
03/2008
-
11/2006 |
2 | Alkylating AgentsIBA
09/2007
-
02/2002 |
2 | Mitochondrial DNA (mtDNA)IBA
12/2006
-
09/2003 |
2 | Free RadicalsIBA
09/2003
-
05/2003 |
1 | CYC065IBA
01/2022 |
1 | RNA Polymerase II (RNA Polymerase B)IBA
01/2022 |
1 | obinutuzumabIBA
12/2021 |
1 | 14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA
01/2021 |
1 | TrabectedinIBA
12/2019 |
1 | fibroblast growth factor 21IBA
11/2019 |
1 | Triglycerides (Triacylglycerol)IBA
11/2019 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018 |
1 | Drug CombinationsIBA
01/2018 |
1 | Taxoids (Taxanes)IBA
01/2018 |
1 | Platinum Compounds (Compounds, Platinum)IBA
01/2018 |
1 | 2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2017 |
1 | Histone Deacetylase InhibitorsIBA
01/2016 |
1 | Histone Deacetylases (Histone Deacetylase)IBA
01/2016 |
1 | Arginine (L-Arginine)FDA Link
06/2015 |
1 | Cyclin-Dependent Kinase 9IBA
02/2015 |
1 | Nucleoside Transport Proteins (Nucleoside Transporter)IBA
04/2014 |
1 | triciribine phosphateIBA
11/2013 |